I’m determined to build a large flow of dividend income in the years ahead. WCM Global Growth Ltd (ASX: WQG) is one of the main names I’m using to build passive income

When I’m thinking about building a stream of dividends, there’s normally a few factors I want to see.

For me, I’m looking for a strong dividend yield, a record of dividend growth, and strong prospects for further payout growth. Let’s run through why the listed investment company (LIC) ticks those boxes so effectively.

Good dividend yield

The ASX stock is already delivering impressive dividend payments to shareholders each year.

During the 2026 financial year, the LIC’s board of directors decided to pay investors four quarterly dividends during the year, totalling 8.52 cents per share.

At the time of writing, this trailing dividend yield translates into a dividend yield of 4% excluding franking credits and 5.8% including franking credits.

But that’s the past. I think investors should focus on what the business’s upcoming dividends could be, since those are the next payouts from the company.

Dividend growth

WCM Global Growth has an impressive dividend history with how it’s increasing its quarterly dividend payment every quarter.

The LIC recently announced its quarterly dividend for the quarter ended 30 June 2026 will be 2.35 cents per share.

It also announced what the next four quarters of dividends will be.

For the three months to September 2026, it will pay 2.45 cents per share.

For the three months to December 2026, it will pay 2.50 cents per share.

For the three months to March 2027, it will pay 2.55 cents per share.

For the three months to June 2027, it will pay 2.60 cents per share.

Those four dividends come to 10.1 cents per share, which translates into a grossed-up dividend yield of 6.9%, including franking credits, at the time of writing.

It also implies that the FY27 fourth quarter passive dividend income will be 10.6% higher than the FY26 fourth-quarter dividend.

Likely payout growth

Dividends are not guaranteed of course, but I think the investment style of the LIC makes it more likely that the business can deliver further dividend growth.

WCM is looking across the global stock market – a big hunting ground – for businesses that have an improving economic moat and a corporate culture that supports the strengthening of the economic moat.

One of the main ways that WCM measures whether a business is improving is looking to see whether it has a rising return on invested capital (ROIC).

Good investment returns make dividend growth much more likely, in my view.

Since the LIC’s inception in June 2017, its net return has averaged 15.6%. That’s been more than enough to pay good dividends and deliver capital growth.

$10,000 of annual passive income

Over the year ahead, I’m expecting WCM Global Growth to pay 10.1 cents per share over the next year.

If the LIC delivers that, then it would require 99,010 WCM Global shares to unlock $10,000 of annual passive income. I think that’d be a compelling investment to make because of the high-quality, global portfolio that it would come with and the pleasing level of passive income.

The post I’d buy 99,010 shares of this ASX stock to aim for $10,000 of annual passive income appeared first on The Motley Fool Australia.

More reading

• How much do I need to retire on $75,000 a year at 45?
• 33 ASX shares going ex-dividend next week
• How much is needed in superannuation to target a $70,000 annual passive income?
• How much is needed in superannuation to target a $60,000 annual passive income?
• How much is needed in superannuation to target a $2,500 monthly passive income?

Motley Fool contributor Tristan Harrison has positions in Wcm Global Growth. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

If you are looking for big potential returns, then Mesoblast Ltd (ASX: MSB) shares could be worth considering.

That’s because the team at Bell Potter believes this biotechnology company’s shares could more than double in value over the next 12 months.

What is the broker saying?

Bell Potter notes that the US FDA has approved an additional potency assay for Ryoncil. It was pleased with the news, given its past experience with potency assays. It explains:

Investors familiar with the journey of Ryoncil through the FDA will be painfully aware of the delays to commercialisation, attributable at least in part, to perceived shortcomings in the then potency assays. Potency measurement is complex in a biological asset, particularly where the starting material may differ from batch to batch and with a multifactorial mechanism of action. 

MSB had not previously disclosed the development of this assay, however, it collaborated with the FDA on the project. The assay will be part of a quality control matrix for the release of each batch of Ryoncil in conjunction with the existing potency assays for IL-2Ra inhibition and CAP (Cell Adhesion and Proliferation). At its core, Ryoncil is a highly potent anti-inflammatory designed to suppress multiple mechanisms of the immune system response to a bone marrow graft by the host, including the proliferation of host T-cells which form part of the cytokine storm that occurs during severe GvHD.

The broker feels this could be a major de-risking event. It adds:

In practical terms, the assay completes the QA circle and represents a significant derisking event. The company is entirely dependent on a single manufacturing site at Lonza, Singapore for the production of Ryoncil. The new assay pavs the way for MSB to commission a second manufacturing site, most likely in the US. We expect this may commence with a second contract manufacturer. The assay allows the company to further tighten the manufacturing specifications on commercial batches.

The assay will be equally applicable to the manufacture of rexlemestrocel-L. MSB has extensive IP around both Ryoncil and Rexlemestrocel-L (aka Revascor). Ryoncil carries Orphan Drug Designation and long life patents. The development of the new TIBA assay further extends the moat around future revenues.

Should you buy Mesoblast shares?

According to the note, in response to the news, the broker has retained its buy rating and $4.45 price target on Mesoblast shares.

Based on its current share price of $2.16, this implies potential upside of 106% for investors over the next 12 months.

The post Could Mesoblast shares rise over 100% in 12 months? appeared first on The Motley Fool Australia.

More reading

• 5 things to watch on the ASX 200 on Monday
• Mesoblast wins FDA nod for new Ryoncil potency test
• 2 ASX 200 shares tipped by brokers to return 73% and 83%
• Brokers rate these 5 ASX shares as a strong buy, and tip upsides of 28% to 62%
• 7 ASX healthcare stock picks from Bell Potter

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Lynas Rare Earths vs Mineral Resources shares: Which mining stock has more upside?

Investors looking at Australia’s mining sector might find themselves weighing Lynas Rare Earths Ltd (ASX: LYC) against Mineral Resources Ltd (ASX: MIN). Both are heavyweights with exposure to crucial elements for the green energy transition, but their businesses, financial metrics, and risk/reward profiles differ sharply. Here’s how these two ASX mining stocks stack up if you’re hunting for upside potential.

The case for Lynas Rare Earths

Lynas Rare Earths is a globally significant player in a highly specialised field—rare earth elements. As one of the few producers outside China, Lynas mines and processes rare earths primarily at its Mt Weld site in Western Australia and its Malaysian facilities. These critical materials are fundamental for tech like electric vehicles, wind turbines, and other green energy gear. As noted in its latest public snapshot, Lynas is also pushing forward with rare earths supply chain projects in the US, highlighting its growth ambitions and strategic value.

Looking at Lynas’s fundamentals, a few points stand out:

• Market cap: $14.48 billion, making it the larger of these two miners
• P/E ratio: 66.50, signalling high expectations from the market
• Year to date return: 17.93%, a solid gain for 2026 so far

However, Lynas currently pays no dividend, so it’s a pure growth play at present.

The case for Mineral Resources

Mineral Resources offers something different—a diversified mining and mining services business with major exposure to iron ore and lithium. The company not only operates its own mines but also delivers end-to-end mining services across WA and beyond. Its strategy is to build scale and efficiencies, aiming to become a top-five lithium hydroxide producer while supplying iron ore to global markets. As per its company overview, Mineral Resources also has a vertically integrated battery manufacturing ambition, leveraging both resource extraction and downstream processing.

Mineral Resources shows strong credentials on several financial fronts:

• P/E ratio: 10.25, much lower than Lynas’s
• Earnings per share (EPS): 5.338
• Dividend yield: 1.52%, fully franked (100%), so investors get tax-effective income
• Market cap: $10.76 billion
• Year to date return: 2.19%

The company’s dividend history is impressive, with a record of consistent, fully franked payouts spanning more than a decade—something income-focused investors might really value.

Valuation comparison

The numbers tell a story of two very differently positioned miners:

	Lynas Rare Earths	Mineral Resources
Market Cap	$14.48b	$10.76b
P/E Ratio	66.50	10.25
Earnings per Share	0.221	5.338
Dividend Yield	0.00%	1.52% (100% franked)

Lynas’s earnings multiple is more than six times that of Mineral Resources, which suggests the market is pricing in much higher growth or scarcity value for rare earths. Note: Lynas Rare Earths’ reported P/E ratio may be based on a different earnings measure (e.g. underlying or forward earnings) than the EPS figure shown, which is why they may appear inconsistent.

Mineral Resources, by contrast, is trading on a low double-digit earnings multiple and generating sizeable franked dividends for shareholders. This could indicate the stock is valued more on its current earnings power and less on blue-sky potential.

Recent share price performance

Comparing their recent share price action up to 24 September 2026:

• Lynas Rare Earths closed at $14.39 on 24 September 2026, with a year-to-date return of 17.9%. Over the past month, the shares have seen some volatility, swinging between $13.83 and $16.40, but have generally traded higher from their mid-year levels.
• Mineral Resources finished at $54.18 on 24 September 2026, with a year-to-date return of 2.2%. The shares have been more subdued lately, moving between $52.83 and $65.46 during the month, but trending flat to slightly down over this timespan.

Which is the better buy?

If I’m weighing Lynas Rare Earths against Mineral Resources with upside in mind, my pick would be Lynas Rare Earths. The market is clearly pricing in strong long-term growth as rare earths play a bigger part in electric vehicle and renewable supply chains. While its high P/E means it’s priced for a lot of future success—and it doesn’t pay a dividend—the company is uniquely placed outside of China and has achieved momentum this year.

Mineral Resources is no slouch, with a solid (and fully franked) dividend and much lower valuation. It’s arguably the steadier play, especially for those seeking income or concerned about volatile commodity cycles. But for investors squarely focused on capital growth and long-term thematic tailwinds, I’d lean toward Lynas despite the market optimism already baked in.

The post Lynas Rare Earths vs Mineral Resources: Which ASX mining stock shines? appeared first on The Motley Fool Australia.

More reading

• Why I’d invest $50,000 of superannuation in New Hope, Mineral Resources and BHP shares
• Buy, hold, sell: BOQ, Harvey Norman, Lynas shares
• Why has the Mineral Resources share price fallen 12% this week?
• Could this evolving development smash ASX lithium shares like Liontown, Mineral Resources and PLS?
• UBS names its 10 top ASX picks for the next 3-6 months

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Lynas Rare Earths Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial draft. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.